van Hoof et al., 2012 - Google Patents
Proteomic analysis of stem cell differentiation and early developmentvan Hoof et al., 2012
View PDF- Document ID
- 17928012122150189553
- Author
- van Hoof D
- Krijgsveld J
- Mummery C
- Publication year
- Publication venue
- Cold Spring Harbor perspectives in biology
External Links
Snippet
Genomics methodologies have advanced to the extent that it is now possible to interrogate the gene expression in a single cell but proteomics has traditionally lagged behind and required much greater cellular input and was not quantitative. Coupling protein with gene …
- 238000000575 proteomic 0 title abstract description 60
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/1034—Isolating an individual clone by screening libraries
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6869—Methods for sequencing
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues ; Not used, see subgroups
Similar Documents
Publication | Publication Date | Title |
---|---|---|
van Hoof et al. | Proteomic analysis of stem cell differentiation and early development | |
Bertero et al. | The SMAD2/3 interactome reveals that TGFβ controls m6A mRNA methylation in pluripotency | |
Yang et al. | Multi-omic profiling reveals dynamics of the phased progression of pluripotency | |
Gao et al. | Protein expression landscape of mouse embryos during pre-implantation development | |
Van Damme et al. | A manually curated network of the PML nuclear body interactome reveals an important role for PML-NBs in SUMOylation dynamics | |
Mortensen et al. | MSQuant, an open source platform for mass spectrometry-based quantitative proteomics | |
Voigt et al. | Asymmetrically modified nucleosomes | |
Dziembowski et al. | Recent developments in the analysis of protein complexes | |
Rigbolt et al. | Quantitative phosphoproteomics to characterize signaling networks | |
Mullari et al. | Specifying RNA-binding regions in proteins by peptide cross-linking and affinity purification | |
Oeffinger | Two steps forward—one step back: advances in affinity purification mass spectrometry of macromolecular complexes | |
Morsy et al. | Charting plant interactomes: possibilities and challenges | |
Lau et al. | Unique properties of a subset of human pluripotent stem cells with high capacity for self-renewal | |
Carneiro et al. | Identifying novel protein interactions: Proteomic methods, optimisation approaches and data analysis pipelines | |
Tian et al. | Rare cell proteomic reactor applied to stable isotope labeling by amino acids in cell culture (SILAC)-based quantitative proteomics study of human embryonic stem cell differentiation | |
Weldemariam et al. | Subcellular proteome landscape of human embryonic stem cells revealed missing membrane proteins | |
Le Sage et al. | Proximity‐dependent biotinylation for identification of interacting proteins | |
Van Hoof et al. | Embryonic stem cell proteomics | |
Budnik et al. | In‐depth analysis of proteomic and genomic fluctuations during the time course of human embryonic stem cells directed differentiation into beta cells | |
Liberski et al. | Adaptation of a commonly used, chemically defined medium for human embryonic stem cells to stable isotope labeling with amino acids in cell culture | |
Harkness et al. | Identification of a membrane proteomic signature for human embryonic stem cells independent of culture conditions | |
Reiland et al. | Defining pluripotent stem cells through quantitative proteomic analysis | |
van den Berg et al. | Dynamic post-transcriptional regulation during embryonic stem cell differentiation | |
Pfeiffer et al. | Proximity labeling for investigating protein-protein interactions | |
Vuoristo et al. | DUX4 regulates oocyte to embryo transition in human |